Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinitapride in mild to moderate functional dyspepsia
NCT01355276Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cinitapride in functional dyspepsia (FD), sponsored by Eisai Co., Ltd.. Started Oct 2010; status: completed.
02
Drugs
cinitapride
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT01355276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355276.